During the inaugural event of expanded Process and Analytical Development Laboratories at Lonza Houston, leaders and innovators from the industry look the stage for a panel discussion around process development and commercial readiness for cell & gene therapy manufacturing.


Anthony Davies, Chair, CEO, Dark Horse Consulting

Brian Price, co-founder, Neucore Bio

Heikki Jouttijarvi, SVP & Head of Tech Ops, Adverum Biotechnologies, Inc.

Maxwell De Long, Director and Senior Principal, Individualized Medicines, Genentech

Behnam Ahmadian Baghbaderani, Global Head of CGT Process Development

By clicking "Access Content" you agree to our Legal Disclaimer and the Lonza Privacy and Cookies Policy.

Latest content
Latest briefing from the Knowledge Center